Revvity, Inc. is a science-based solutions company providing reagents, consumables, assays, instruments, and software to the life sciences and diagnostics markets. Its offerings facilitate a range of processes, from research discovery to clinical diagnosis and treatment. The company operates with over 11,000 colleagues globally and generates annual revenue exceeding $2.9 billion.
The company maintains a global operational footprint, with its headquarters in Waltham, Massachusetts, and business activities in more than 190 countries. Its customer base spans multiple industry verticals, including pharmaceutical, biotechnology, diagnostic laboratories, academia, and government agencies.
Revvity is listed as part of the S&P 500 index. Its work is centered in technical domains such as life sciences, diagnostics, automation, multi-omics, and software. The organization focuses on cross-business collaborations and innovation as part of its translational approach to improving health outcomes.
